DGAP-News

Dr. Michael Schneider appointed new CFO of NORMA Group

DGAP-News: NORMA Group SE / Key word(s): Change of Personnel/Contract
Dr. Michael Schneider appointed new CFO of NORMA Group

30.01.2015 / 08:51

---------------------------------------------------------------------

Dr. Michael Schneider appointed new CFO of NORMA Group

Maintal, Germany, 30 January 2015 - The Supervisory Board of NORMA Group SE
("NORMA Group"), a global market leader in engineered joining technology,
has appointed Dr. Michael Schneider to be the company's new Chief Financial
Officer by September 2015 at the very latest. He will succeed Dr. Othmar
Belker, who will leave NORMA Group by mutual agreement end of March 2015.
Werner Deggim, CEO of NORMA Group, will attend to the tasks of the CFO
during the transition phase.

Dr. Michael Schneider has many years of experience working in the areas of
Finance and Controlling in the automotive, chemical and pharmaceutical
industries. He joins NORMA Group from FTE automotive GmbH, a globally
active supplier of hydraulic brake and clutch systems for the automotive
industry. As its CFO, Dr. Schneider is responsible for all areas of
Finance, but also Purchasing and IT. Previous to this position, he served
as the CFO of the automotive industry supplier Veritas AG. Dr. Schneider
began his professional career in 1988 with Hoechst AG (now Sanofi SA) and
then joined Degussa AG (today EVONIK Industries AG) in 1993. From 1997
until 2000, he was responsible for the areas of Controlling and Accounting
at Degussa Brasil in São Paulo. Dr. Schneider has a degree in business
administration and received his PhD in the area of economic sciences from
Justus Liebig University in Gießen.

"I am pleased to see Dr. Schneider appointed CFO of NORMA Group and I am
certain that he will carry on with NORMA Group's successful strategy
together with his fellow Board members. Dr. Schneider has a great deal of
knowledge of finance and has gained in-depth industry experience both in
Germany and abroad," says Dr. Stefan Wolf, Chairman of the Supervisory
Board of NORMA Group.

Dr. Othmar Belker took office as CFO in 2006 and was responsible for
setting up the international finance department at NORMA Group. He also
played a lead role in preparing the company's IPO in 2011 and in the
refinancing measures that followed. "I would like to expressly thank Dr.
Belker for his contribution to the success of NORMA Group SE these last few
years. He was instrumental in preparing the successful IPO and in
organizing Group financing," Dr. Wolf says.